The growth of the API industry is affected by fluctuations in the drug market, which are caused by new drug launches, emerging market growth, and generic drug market growth, as well as the waves of drug patent expirations in Europe and America, among others. The international API supply is deficient given stricter approvals in the United States, Europe, and Japan for importing API. Although these approvals lead to tight supply in the API market and changes in market shares, improving the quality of the global API industry in the future is foreseeable.
I. Definition and Scope of the Industry
II. Overview of the 2014 Pharmaceutical Industry
III. Market Niches and Competitive Assessments
IV. Market Forecasts and Trends
V. Recommendations for Developing Taiwan’s Pharmaceutical Industry
Figure 1 Forecast of Global Drug Market Sales and Growth for 2007–2020
Figure 2 Future Drug Markets of Major Countries and Comparison of RRR
Table 1 Categories of Taiwan’s Pharmaceutical Industry
Table 2 Overview of Pharmaceutical Environment in Major Markets
Table 3 Overview of Pharmaceutical Environment in Emerging Markets
Table 4 Outlook for Global Pharmaceutical Industry
Table 5 Recommendations for Developing Taiwan's Pharmaceutical Industry